FDA panel to discuss Solesta, Lap-Band

The Gastroenterology and Urology Devices Panel of FDA's Medical Devices Advisory Committee will meet on Dec. 2 to discuss a PMA from Oceana Therapeutics Inc. (Edison, N.J.) for Solesta to treat fecal incontinence. Oceana has exclusive worldwide rights to the injectable hyaluronic acid biocompatible from Q-Med AB (SSE:QMED). Q-Med was up SEK1 to SEK68.75. ...